Pharmaceutical

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.

Feb 20, 2024 - 18:00
RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.
Read the original article

Tags:

Previous Article

RioDerm-004 by Rion for Fistula: Likelihood of Approval

Next Article

SY-001 by CellOrigin Technology (Hangzhou) for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharmanovia signs license agreement for Lindis Biotech’s catumaxomab

Pharmanovia signs license agreement for Lindis Biotech’...

Nov 21, 2024

Preparation over panic: How a Boston hospital is priming medical residents for an era of AI medicine

Preparation over panic: How a Boston hospital is primin...

Jul 20, 2023

Non-profit receives FDA approval to supply cheaper OTC naloxone

Non-profit receives FDA approval to supply cheaper OTC ...

Jul 31, 2023